ReWalk Robotics Ltd.
1.46
-0.10 (-6.41%)
At close: Jan 14, 2025, 3:59 PM
1.76
20.96%
Pre-market Jan 15, 2025, 04:05 AM EST

Company Description

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa.

The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.

It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors.

The company was formerly known as Argo Medical Technologies Ltd.

ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

ReWalk Robotics Ltd.
ReWalk Robotics Ltd. logo
Country IL
IPO Date Sep 12, 2014
Industry Medical - Devices
Sector Healthcare
Employees 108
CEO Lawrence J. Jasinski BS, MBA

Contact Details

Address:
3 Hatnufa Street
Yokneam Illit,
IL
Website https://www.rewalk.com

Stock Details

Ticker Symbol LFWD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001607962
CUSIP Number n/a
ISIN Number IL0011331076
Employer ID 00-0000000
SIC Code 3842

Key Executives

Name Position
Lawrence J. Jasinski BS, MBA Chief Executive Officer & Director
Michael A. Lawless Chief Financial Officer
Almog Adar Vice President of Finance & Chief Accounting Officer
Jeannine Lynch Vice President of Market Access & Strategy
Judy Kula Vice President of Customer Service, Human Resources & Business Affairs
Kathleen O'Donnell Vice President of Marketing & New Business Development
Miri Pariente Vice President of Operations, Regulatory & Quality

Latest SEC Filings

Date Type Title
Jan 14, 2025 SCHEDULE 13G Filing
Jan 13, 2025 D Filing
Jan 13, 2025 8-K Current Report
Jan 08, 2025 SCHEDULE 13G Filing
Jan 08, 2025 4 Filing
Jan 08, 2025 8-K/A [Amend] Current Report
Jan 08, 2025 8-K Current Report
Jan 08, 2025 424B5 Filing
Dec 27, 2024 DEFA14A Filing
Dec 17, 2024 4 Filing